Melbourne, AU - March 30, 2020 - PRESS RELEASE
To help protect eye care professionals and their patients during the threat of COVID-19, Oculo is introducing video conferencing to support teleophthalmology and teleoptometry. The secure, high fidelity, stable service connects patients with optometrists and ophthalmologists, so that they can connect with each other and with their patients while reducing the need for in-person consultations.
“The coronavirus pandemic is creating unprecedented strains on health systems. At the same time, the eye care needs for people with pre-existing chronic diseases - including diabetic eye disease, glaucoma and macular disease - are unchanged.” states Dr Kate Taylor, CEO of Oculo.
Launching next week for Oculo customers is the ability to conduct teleconsultations directly from the Oculo platform. This new feature will allow optometrists and ophthalmologists to continue delivering care to their patients who require ongoing support to manage chronic conditions.
Professor Bill Morgan of the Lions Eye Institute in Perth notes, “Patients with glaucoma and AMD are on average in their 70’s and 80’s, a known risk factor for an adverse outcome with COVID-19 ( ~ 15% mortality). Diabetes patients tend to be somewhat younger (typically in their 60s), but because diabetes is a known significant risk factor, they fall into the high risk COVID-19 band also.”
“We want to work with the community to protect patients both from infection with COVID-19 and preventable vision loss. We are also deeply concerned about the health and wellbeing of everyone who works in eye care. We have built the new video conferencing feature to support ongoing care while alleviating the risks posed by close contact," explains Dr Taylor. “It’s part of our ongoing commitment to promote security, privacy and quality care.”
For a video demonstration of how this new teleconsultation feature works, please click here.
Oculo is a secure, cloud-based clinical communications network designed to support telemedicine including teleoptometry and teleophthalmology, better triage and screening to connect clinicians around their patients, facilitating seamless co-managed care. The Oculo platform facilitates the secure, instant transfer of clinical imaging, referrals, and other clinical correspondence between healthcare professionals.
Oculo was founded by the Centre for Eye Research Australia and is based in Melbourne, Australia. Since launching in 2015, Oculo has grown a user base of over 3,600 clinicians in Australia and New Zealand and has managed over 791,000 patients. Oculo is also the technology partner for KeepSight, a first-ever national diabetes eye care program funded by the Australian government in a public-private partnership.
Oculo is now working to connect clinicians around their patients around the world. In March 2019, Oculo partnered with Topcon Healthcare Solutions (THS), a global leader in eye care devices and image management.
Dr Kate Taylor
CEO & Founder
T: +61 (0)3 8592 7079
Here is where you will find who we are, why we do what we do, and all our latest news.